mortality/aging
|
• age of onset E9.5
|
liver/biliary system
|
hm1
|
Tsc2tm1Djk/Tsc2tm1Djk
either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J) |
|
|||||||||||||||||
|
• age of onset E9.5
|
|
ht2
|
Tsc2tm1Djk/Tsc2+
either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J) |
|
|||||||||||||||||
|
• reported at 15 months of age
• Background Sensitivity: note that the tumor expression pattern is influenced by genetic background; authors note fewer large renal cystadenomas in outbred Black Swiss background and more angiosarcomas in 129S4/SvJae chimeric mice
|
|
• 50% incidence; causes fatal bleeding in 10% of these cases
|
|
• 32% incidence
|
|
• 100% incidence
|
|
• less than 10% incidence
|
|
• less than 10% incidence
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Tuberous Sclerosis 2; TSC2 | 613254 | J:57631 | |
|
ht3
|
Tsc2tm1Djk/Tsc2+
involves: 129S4/SvJae * C57BL/6NCrl |
|
|||||||||||||||||
| N |
• mice exhibit normal motor skills, exploratory behavior, anxiety and social approach behavior
(J:138621)
|
|
• following contextual conditioning, mice exhibit reduced freezing compared to wild-type mice
• however, treatment with rapamycin re-establishes normal contextual conditioning
|
|
• in a hippocampus-dependent version of the Morris water maze test, spatial learning is impaired compared to in wild-type mice
• however, spatial learning in a hippocampus-independent water maze is normal and treatment with rapamycin re-establishes normal spatial learning
• mice exhibit more across-phase errors compared to in wild-type mice in a hippocampus-dependent win-shift version of the eight-arm radial maze
|
| N |
• mice exhibit normal basal synaptic transmission, paired-pulse facilitation and early-phase long term potentiation
(J:138621)
|
|
• mice exhibit lowered late-phase threshold for long term potentiation compared to in wild-type mice
• however, treatment with rapamycin re-establishes normal late-phase long term potentiation
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Tuberous Sclerosis 2; TSC2 | 613254 | J:138621 | |